| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 647 | DDX0141A647-100 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-05772SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-49879-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26878-25ul | |||
| Azide and BSA Free | NBP3-44281 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-48330 | |||
| Azide and BSA Free | NBP3-11580 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26159-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-18646-0.02mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43978 | |||
| BSA Free | NBP2-30982-25ul | |||
![Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (LL2) [DDX0141P-100] - IF staining of hCD40L-transfected cellswith LL2 clone](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-LL2-Immunocytochemistry-Immunofluorescence-DDX0141P-100-img0005.jpg "Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (LL2) [DDX0141P-100] - IF staining of hCD40L-transfected cellswith LL2 clone")
![Flow Cytometry: CD40 Ligand/TNFSF5 Antibody (LL2) [DDX0141P-100] - FACS staining of hCD40L-transfected Lcellswith LL2 clone](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-LL2-Flow-Cytometry-DDX0141P-100-img0002.jpg)
![Blocking/Neutralizing: CD40 Ligand/TNFSF5 Antibody (LL2) [DDX0141P-100] - LL2 inhibitsthe stimulatory effect of the CD40L-transfected L cells on synovial fibroblasts Rissoan et al, Clin Exp Immunol. 1996, 106(3):481-90.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-LL2-Blocking-Neutralizing-DDX0141P-100-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: VEGFR2/KDR/Flk-1 Antibody [NBP3-05772] - HepG2 cells were fixed for 10 minutes using 4% PFA and then permeabilized for 5 minutes using 1X PBS + 0.05% Triton-X100. The cells were incubated with anti-VEGFR2/KDR at 2 ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-05772-img0002.jpg "Immunocytochemistry/Immunofluorescence: VEGFR2/KDR/Flk-1 Antibody [NBP3-05772] - HepG2 cells were fixed for 10 minutes using 4% PFA and then permeabilized for 5 minutes using 1X PBS + 0.05% Triton-X100. The cells were incubated with anti-VEGFR2/KDR at 2 ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.")
![Immunohistochemistry-Paraffin: VEGFR2/KDR/Flk-1 Antibody [NBP3-05772] - Analysis of a FFPE tissue section of mouse kidney using 1:200 dilution of VEGFR2 antibody. The staining was developed using HRP labeled anti-rabbit secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-Immunohistochemistry-Paraffin-NBP3-05772-img0001.jpg)
![SDS-Page: Recombinant Human CD34 His Protein [NBP2-53044] - 3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain](http://images.novusbio.com/fullsize/Recombinant Human CD34 His Protein-SDS-Page-NBP2-53044-img0002.jpg "SDS-Page: Recombinant Human CD34 His Protein [NBP2-53044] - 3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain")
![Immunocytochemistry/Immunofluorescence: SSEA-1 Antibody (FUT4/1478R) [NBP2-49878] - Staining of U937 cells using CD15 Rabbit Recombinant Monoclonal Antibody (FUT4/1478R) followed by goat anti-Mouse IgG conjugated to CF488 (green). Nuclei are stained with Reddot. Image using the Azide and BSA Free format of this antibody.](http://images.novusbio.com/fullsize/SSEA-1-Antibody-FUT4-1478R-Immunocytochemistry-Immunofluorescence-NBP2-49878-img0003.jpg "Immunocytochemistry/Immunofluorescence: SSEA-1 Antibody (FUT4/1478R) [NBP2-49878] - Staining of U937 cells using CD15 Rabbit Recombinant Monoclonal Antibody (FUT4/1478R) followed by goat anti-Mouse IgG conjugated to CF488 (green). Nuclei are stained with Reddot. Image using the Azide and BSA Free format of this antibody.")
![Immunohistochemistry-Paraffin: SSEA-1 Antibody (FUT4/1478R) [NBP2-49878] - human Hodgkin's Lymphoma stained with CD15 Rabbit Monoclonal Antibody (FUT4/1478R).](http://images.novusbio.com/fullsize/SSEA-1-Antibody-FUT4-1478R-Immunohistochemistry-Paraffin-NBP2-49878-img0001.jpg)
![Flow Cytometry: SSEA-1 Antibody (FUT4/1478R) [NBP2-49878] - Analysis of U937 cells using CD15 Rabbit Recombinant Monoclonal Antibody (FUT4/1478R) followed by goat anti-rabbit IgG-CF488 (Blue); Isotype Control (Red). Image using the Azide and BSA Free format of this antibody.](http://images.novusbio.com/fullsize/SSEA-1-Antibody-FUT4-1478R-Flow-Cytometry-NBP2-49878-img0002.jpg)
![Western Blot: CD40 Ligand/TNFSF5 Antibody [NBP1-91770] - Analysis in control (vector only transfected HEK293T lysate) and cD40LG over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-Western-Blot-NBP1-91770-img0007.jpg "Western Blot: CD40 Ligand/TNFSF5 Antibody [NBP1-91770] - Analysis in control (vector only transfected HEK293T lysate) and cD40LG over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells.")
![Immunohistochemistry-Paraffin: CD40 Ligand/TNFSF5 Antibody [NBP1-91770] - Staining of human rectum shows strong cytoplasmic positivity in leukocytes.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-Immunohistochemistry-Paraffin-NBP1-91770-img0011.jpg)
![Immunohistochemistry-Paraffin: CD40 Ligand/TNFSF5 Antibody [NBP1-91770] - Staining of human cerebral cortex shows no positivity in neurons as expected.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-Immunohistochemistry-Paraffin-NBP1-91770-img0008.jpg)
![Immunohistochemistry-Paraffin: CD40 Ligand/TNFSF5 Antibody [NBP1-91770] - Staining of human lymph node shows strong cytoplasmic positivity in leukocytes.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-Immunohistochemistry-Paraffin-NBP1-91770-img0009.jpg)
![Immunohistochemistry: CD40 Ligand/TNFSF5 Antibody [NBP1-91770] - Staining of human pancreas shows no positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-Immunohistochemistry-NBP1-91770-img0010.jpg)
![Immunocytochemistry/Immunofluorescence: CD15/Lewis X Antibody (4E10) [NBP2-22179] - Immunofluorescence analysis of PC-2 cells using CD15 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/CD15-Lewis-X-Antibody-4E10-Immunocytochemistry-Immunofluorescence-NBP2-22179-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD15/Lewis X Antibody (4E10) [NBP2-22179] - Immunofluorescence analysis of PC-2 cells using CD15 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.")
![Immunohistochemistry-Paraffin: CD15/Lewis X Antibody (4E10) [NBP2-22179] - Immunohistochemical analysis of paraffin-embedded human cerebellum tissues (left) and human liver cancer tissues (right) using CD15 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CD15-Lewis-X-Antibody-4E10-Immunohistochemistry-Paraffin-NBP2-22179-img0002.jpg)
![ELISA: CD15/Lewis X Antibody (4E10) [NBP2-22179] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng)](http://images.novusbio.com/fullsize/CD15-Lewis-X-Antibody-4E10-ELISA-NBP2-22179-img0003.jpg)
![Western Blot: CD31/PECAM-1 Antibody (C31.10) [NBP2-44340] - Western Blot Analysis of human Jurkat cell lysate using CD31/PECAM-1 Antibody (C31.10).](http://images.novusbio.com/fullsize/CD31-PECAM-1-Antibody-C31-10-Western-Blot-NBP2-44340-img0005.jpg "Western Blot: CD31/PECAM-1 Antibody (C31.10) [NBP2-44340] - Western Blot Analysis of human Jurkat cell lysate using CD31/PECAM-1 Antibody (C31.10).")
![Immunohistochemistry-Paraffin: CD31/PECAM-1 Antibody (C31.10) [NBP2-44340] - Human Tonsil stained with CD31/PECAM-1 Antibody (C31.10).](http://images.novusbio.com/fullsize/CD31-PECAM-1-Antibody-C31-10-Immunohistochemistry-Paraffin-NBP2-44340-img0003.jpg)
![Flow Cytometry: CD31/PECAM-1 Antibody (C31.10) [NBP2-44340] - Flow Cytometry of human CD31 on Jurkat cells. Black: cells alone; Grey: Isotype Control; Green: AF488-labeled CD31/PECAM-1 Antibody (C31.10).](http://images.novusbio.com/fullsize/CD31-PECAM-1-Antibody-C31-10-Flow-Cytometry-NBP2-44340-img0004.jpg)
![Immunohistochemistry-Paraffin: CD31/PECAM-1 Antibody (C31.10) [NBP2-44340] - Human Angiosarcoma stained with CD31/PECAM-1 Antibody (C31.10).](http://images.novusbio.com/fullsize/CD31-PECAM-1-Antibody-C31-10-Immunohistochemistry-Paraffin-NBP2-44340-img0002.jpg)
![Flow Cytometry: CD31/PECAM-1 Antibody (C31.10) [NBP2-44340] - Human CD31 on Jurkat Cells. Black: Cells alone; Grey: Isotype Control; Green: AF488-labeled CD31/PECAM-1 Antibody (C31.10).](http://images.novusbio.com/fullsize/CD31-PECAM-1-Antibody-C31-10-Flow-Cytometry-NBP2-44340-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: LYVE-1 Antibody (11C11) [NBP3-26159] - Staining of HepG2 with LYVE-1 Antibody (11C11) at 1:25, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 505-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26159_rabbit-lyve-1-mab-11c11-28220241249369.jpg "Immunocytochemistry/Immunofluorescence: LYVE-1 Antibody (11C11) [NBP3-26159] - Staining of HepG2 with LYVE-1 Antibody (11C11) at 1:25, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 505-conjugated Goat Anti-Rabbit IgG (H+L).")
![Flow Cytometry: LYVE-1 Antibody (11C11) [NBP3-26159] - Overlay Peak curve showing HepG2 cells stained with LYVE-1 Antibody (11C11) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26159_rabbit-lyve-1-mab-11c11-28220241418361.jpg)
![Western Blot: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - VEGFR2/KDR/Flk-1 Antibody (20I6) [NBP1-18646] - Recombinant human endogenous soluble VEGFR-2/KDR (esKDR) was produced in insect cells. Western blot was performed using our monoclonal anti-VEGFR-2 recognizing the soluble as well as the transmembrane form of KDR (left panal) and our new poyclonal antibody directed against the unique C-terminal end of the endogenous sKDR (CGRETILDHSAEAVGMP) recognizing solely the endogenous form but not sKDR (D7) and sKDR (D7)-Fc consisting of the full extraplasmatic domain. The endogenous sKDR generated by alternative splicing consists of the first 6 Ig-like loops with a unique c-terminal end.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-20I6-Western-Blot-NBP1-18646-img0006.jpg "Western Blot: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - VEGFR2/KDR/Flk-1 Antibody (20I6) [NBP1-18646] - Recombinant human endogenous soluble VEGFR-2/KDR (esKDR) was produced in insect cells. Western blot was performed using our monoclonal anti-VEGFR-2 recognizing the soluble as well as the transmembrane form of KDR (left panal) and our new poyclonal antibody directed against the unique C-terminal end of the endogenous sKDR (CGRETILDHSAEAVGMP) recognizing solely the endogenous form but not sKDR (D7) and sKDR (D7)-Fc consisting of the full extraplasmatic domain. The endogenous sKDR generated by alternative splicing consists of the first 6 Ig-like loops with a unique c-terminal end.")
![Immunocytochemistry/Immunofluorescence: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - HMEC-1 CRL-3243 cells, stained with 1:50 VEGFR2/KDR/Flk-1 antibody (NBP1-18645AF488) (green) and DAPI (blue). Image from verified customer review.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-20I6-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP1-18646-img0016.jpg)
![Flow Cytometry: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - VEGFR2/KDR/Flk-1 Antibody (20I6) [NBP1-18646] - Analysis with primary human dermal lymphatic endothelial cells(HDLEC).](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-20I6-Flow-Cytometry-NBP1-18646-img0009.jpg)
![Immunocytochemistry/Immunofluorescence: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - VEGFR2/KDR/Flk-1 Antibody (20I6) [NBP1-18646] - Staining (green) of VEGFR-2 (KDR) in primary human umbilical vein endothelial cells (HUVEC) with anti-human VEGFR-2 (Cl.4) (7,5ug/ml) and counter staining of nuclei with Dapi. As secondary antibody goat anti-mouse ALEXA Flour 488 (Dianova) was used 1:600.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-20I6-Immunocytochemistry-Immunofluorescence-NBP1-18646-img0015.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining in human placenta and tonsil tissues. Corresponding FLT1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0011.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining in human placenta and tonsil tissues. Corresponding FLT1 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Lane 1: Marker [kDa] Lane 2: Human cell line RT-4](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Western-Blot-NBP2-30982-img0005.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining of human placenta shows strong cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0007.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining of human kidney shows strong cytoplasmic positivity in endothelial cells.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0008.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining of human small intestine shows moderate to strong cytoplasmic positivity in endothelial cells, as well as positivity in smooth muscle cells.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0009.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining of human tonsil shows no positivity in lymphoid cells as expected.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0010.jpg)